Stocks and Investing Stocks and Investing
Wed, December 18, 2019
[ 12:00 AM ] - WOPRAI
Michael Carroll Downgraded (ARE) to Buy and Increased Target to $165 on, Dec 18th, 2019
[ 12:00 AM ] - WOPRAI
Craig Hettenbach Maintained (APH) at Buy with Increased Target to $28 on, Dec 18th, 2019
Tue, December 17, 2019
[ 12:00 AM ] - WOPRAI
Liana Moussatos Maintained (AQST) at Buy with Decreased Target to $34 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Joseph Spak Initiated (APH) at Hold and Held Target at $28 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Adam Jonas Maintained (ABG) at Hold with Decreased Target to $111 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Krish Sankar Maintained (AAPL) at Buy with Increased Target to $81 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Mark Miller Maintained (ACMR) at Strong Buy with Increased Target to $6.67 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (ABT) at Buy with Increased Target to $101 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Raj Sharma Initiated (UTI) at Strong Buy and Held Target at $9 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (ZBH) at Buy with Increased Target to $170 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Gagliano Downgraded (AA) to Hold and Decreased Target to $23 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
John Walsh Maintained (AYI) at Buy with Increased Target to $144 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Matthew Harrigan Initiated (BATRA) at Strong Buy and Held Target at $35 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Matthew Harrigan Initiated (BATRK) at Strong Buy and Held Target at $35 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Richard Davis Maintained (BAND) at Strong Buy with Increased Target to $70 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lewis Downgraded (BAX) to Hold and Decreased Target to $88 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Peter Arment Maintained (BA) at Hold with Decreased Target to $322 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Simon Flannery Downgraded (BCE) to Sell on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (BDX) at Hold with Increased Target to $287 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (ALNY) at Buy with Increased Target to $150 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Matthew Harrison Initiated (AMGN) at Buy and Held Target at $280 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (ALC) at Buy with Decreased Target to $70 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (SYK) at Buy with Increased Target to $242 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Jun Zhang Downgraded (SYNA) to Strong Sell and Held Target at $45 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Initiated (SUM) at Strong Buy and Held Target at $30 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Brennan Hawken Maintained (STT) at Hold with Increased Target to $81 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Szeho Ng Upgraded (TSM) to Strong Buy on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Brennan Hawken Maintained (BK) at Strong Buy with Increased Target to $58 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
Neel Kumar Initiated (AVY) at Hold and Held Target at $137 on, Dec 17th, 2019
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (AVNS) at Sell with Decreased Target to $32 on, Dec 17th, 2019

David Lewis Maintained (AVNS) at Sell with Decreased Target to $32 on, Dec 17th, 2019


Published on 2024-10-26 19:13:51 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Decreased Target from $36 to $32 on, Dec 17th, 2019.

David has made no other calls on AVNS in the last 4 months.



There are 2 other peers that have a rating on AVNS. Out of the 2 peers that are also analyzing AVNS, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Rick Wise of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Thursday, November 7th, 2019


This is the rating of the analyst that currently disagrees with David

  • Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $48 on, Wednesday, November 6th, 2019
Contributing Sources